Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06927895 · ClinicalTrials.gov registry record · NA
Breast Cancer Implementation Science Study With Educational Intervention
A NA study, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT06927895 is a NA study that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 30 participants.
The verdict
NCT06927895, a NA study, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
A study uniquely focused on system-based practice change, measuring the impact of educational interventions on both patients and clinicians for the recognition and management of treatment-related adverse effects for HER2+/HER2 low breast cancer patients on or about to start on HER2 targeted antibody drug conjugates (fam-trastuzumab deruxtecan-nxki or ado-trastuzumab emtansine) and shared decision-making methodologies to improve adverse event (AE) management and patient-clinician communications.
Interventions
- BEHAVIORAL Educational Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-07-03 |
| Est. Completion | 2027-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06927895
The ClinicalTrials.gov registry entry for NCT06927895 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Educational Intervention is the first listed.
NCT06927895 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06927895 about?
NCT06927895 is a clinical study titled "Breast Cancer Implementation Science Study With Educational Intervention". A study uniquely focused on system-based practice change, measuring the impact of educational interventions on both patients and clinicians for the recognition and management of treatment-related adverse effects for HER2+/HER2 low breast cancer patients on or about to start on HER2 targeted antibody...
What is the current status of trial NCT06927895?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-07-03. Estimated completion is 2027-08-31.
What interventions are being tested in trial NCT06927895?
The interventions under investigation include: Educational Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06927895?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.